CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $246,654
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$246,654. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-21 | Treace John T. Chief Executive Offer | Purchase | +15,000 | $21.83 | $327K | 5,541,455 |
| 2022-11-18 | TIMBIE THOMAS E Director | Sale | −37,605 | $22.66 | $852K | 1,361,464 |
| 2022-11-18 | TIMBIE THOMAS E Director | Sale | −2,101 | $23.46 | $49K | 1,359,363 |
| 2022-11-17 | Elder Scot Michael *See "Remarks" | Purchase | −3,736 | $21.48 | $80K | 22,598 |
| 2022-11-17 | Treace John T. Chief Executive Offer | Purchase | +10,000 | $21.67 | $217K | 5,526,455 |
| 2022-11-16 | TIMBIE THOMAS E Director | Sale | −50,000 | $20.14 | $1.0M | 1,399,069 |
| 2022-11-15 | TREACE JAMES T Director | Sale 10b5-1 | −46,500 | $20.12 | $936K | 1,039,941 |
| 2022-11-15 | TREACE JAMES T Director | Sale 10b5-1 | −1,600 | $21.18 | $34K | 1,038,341 |
| 2022-11-15 | TREACE JAMES T Director | Sale 10b5-1 | −200 | $21.97 | $4K | 1,038,141 |
| 2022-11-15 | TREACE JAMES T Director | Sale 10b5-1 | −1,700 | $24.02 | $41K | 1,036,441 |
| 2022-11-15 | Owens Daniel E. Chief Human Resources Officer | Option exercise | +6,250 | $7.03 | $44K | 16,950 |
| 2022-11-15 | Owens Daniel E. Chief Human Resources Officer | Sale | −6,250 | $20.38 | $127K | 10,700 |
| 2022-11-15 | Owens Daniel E. Chief Human Resources Officer | Option exercise · Stock Option Right to Buy | −6,250 | 186,375 | ||
| 2022-11-14 | Scanlan Sean F. SVP, Marketing | Option exercise | +25,000 | $0.10 | $3K | 34,975 |
| 2022-11-14 | Scanlan Sean F. SVP, Marketing | Sale | −25,000 | $24.27 | $607K | 9,975 |
| 2022-11-14 | Scanlan Sean F. SVP, Marketing | Option exercise · Stock Option (Right to Buy) | −25,000 | $0.10 | $3K | 108,750 |
| 2022-11-10 | BAYS F BARRY Director | Sale | −1,500 | $22.48 | $34K | 1,545,314 |
| 2022-11-10 | BAYS F BARRY Director | Sale | −7,900 | $23.62 | $187K | 1,537,414 |
| 2022-11-09 | BAYS F BARRY Director | Sale | −4,100 | $20.77 | $85K | 1,559,837 |
| 2022-11-09 | BAYS F BARRY Director | Sale | −13,023 | $21.19 | $276K | 1,546,814 |
Page 15 of 19 · 364 trades